Vanguard Group Inc Xenon Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 344,365 shares of XENE stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

344,365

Previous 341,152 0.94%

Holding current value

$13.2 Million

Previous $13.3 Million 1.87%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$36.12 - $43.96 $116,053 - $141,243	3,213 Added 0.94%	344,365 $13.6 Million
Q2 2024 Aug 13, 2024	BUY	$36.25 - $43.75 $199,991 - $241,368	5,517 Added 1.64%	341,152 $13.3 Million
Q1 2024 May 10, 2024	BUY	$42.66 - $50.04 $517,892 - $607,485	12,140 Added 3.75%	335,635 $14.4 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $1.63 Million - $2.63 Million	56,669 Added 21.24%	323,495 $14.9 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $186,957 - $217,442	5,473 Added 2.09%	266,826 $9.11 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $418,045 - $522,436	11,999 Added 4.81%	261,353 $10.1 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $1.92 Million - $2.31 Million	57,278 Added 29.82%	249,354 $8.92 Million
Q4 2022 Feb 10, 2023	BUY	$33.06 - $39.43 $227,585 - $271,436	6,884 Added 3.72%	192,076 $7.57 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $41,474 - $53,637	1,347 Added 0.73%	185,192 $6.69 Million
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $518,390 - $716,455	20,377 Added 12.47%	183,845 $5.59 Million
Q1 2022 May 13, 2022	BUY	$25.09 - $33.13 $253,459 - $334,679	10,102 Added 6.59%	163,468 $5 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $720,314 - $1.63 Million	46,174 Added 43.08%	153,366 $4.79 Million
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $55,814 - $73,054	3,756 Added 3.63%	107,192 $1.64 Million
Q2 2021 Aug 13, 2021	BUY	$16.81 - $20.0 $1.74 Million - $2.07 Million	103,436 New	103,436 $1.93 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Xenon Pharmaceuticals Inc. Transaction History